Delivery Order SPE2DR25D2104-SPE2DR26F3NHP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsule 120-count units, with a contract ceiling value of $3,250.80. This non-set-aside award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, utilizing firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed at AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Icosapent Ethyl 1 gram pharmaceutical product, valued at $1,250.91. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a task under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 gram capsules. The fixed-price contract, valued at $1,567.89, has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) to provide a wide range of medical commodities, including prescription drugs, vaccines, and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $1,302.16 and a period of performance extending through June 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- The Defense Logistics Agency awarded a delivery order valued at $452,250 to Amerisourcebergen Drug Corporation for the provision of 120 capsules of 1 gram Icosapent Ethyl capsules. This firm fixed price order is being carried out under the Prime Vendor Program, with performance taking place in Conshohocken, Pennsylvania from August 18-21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States...
- This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,154 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 120 capsules of 1 gram Icosapent Ethyl capsules to be delivered to a location in Conshohocken, Pennsylvania by August 14, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs and maintains medical...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NHPDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule in quantities of 120 units, with a ceiling value of $3,477.08 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The parent IDV through which this delivery order flows enables the company to furnish specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the vendor's established capability to meet federal medical supply requirements through open competition and firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/4/25 |